Stay Updated with the Latest IRB Infrastructure Developers Limited IRB.NS News in Real Time
Find IRB.NS news now at Meyka AI. Stay informed with the latest IRB Infrastructure Developers Limited stocks updates, including price news, market analysis, and expert insights.
Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2
Yash’s Toxic opens with Rs 101.10 crore net on Day 1, one of India’s biggest openers, but drops 84% on Day 2 to Rs 16.48 crore as mixed reviews and trolls emerge.
Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume
HYPEUSD rallied 3.2% to $85.08 on August 27 following Hyperliquid’s launch of tokenized stocks and AQAv2 buyback engine on August 26.
Singapore Couple Fined S$8,500 After Four Dogs Escape, Injure Labrador on August 25
Singapore couple fined S$8,500 after four unlicensed dogs escaped and injured a Labrador. Rottweilers and Cane Corsos are restricted breeds requiring special approval.
Nepal Floods Kill 359 as Glacier Collapse Triggers Himalayan Disaster; 34 Australians Missing
Glacier collapse in Nepal Himalayas triggers deadly flash floods killing 359 people. 34 Australians among nearly 1,500 missing as rescue efforts continue across Nepal-Tibet border.
Nvidia Guides 70% Growth for Fiscal 2028 After Q2 Revenue Doubles to $96.2B
Nvidia beats Q2 earnings with $96.2B revenue, up 106% YoY. CEO Jensen Huang forecasts 70% fiscal 2028 growth, far exceeding analyst consensus. Data center revenue surges 117% as AI demand accelerates.
US and China Race for Pacific Deep-Sea Mining as Australia Faces Pressure to Act
US and China compete for Pacific deep-sea mining of critical minerals worth USD 30 trillion. Australia faces pressure to shape international governance before operations start in 2027.
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…
Shein Sets Hong Kong IPO Price at HK$48.56, Valuing Fast-Fashion Giant at $26.5 Billion
Shein will price its Hong Kong IPO at HK$48.56 per share, people familiar with the matter said Thursday. The price sits near the midpoint of its HK$47.60 to HK$49.50 marketed range. The deal values Shein at roughly $26.5 billion, confirming weeks of investor pushback on valuation. Final Pricing Details Shein’s pricing will raise approximately HK$13.6…
Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27
Nvidia beat Q2 earnings with $96.2B revenue and $2.22 adjusted EPS, but stock fell 1.6%. Q3 guidance of $108B signals strong AI chip demand ahead.